ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

Immunoassays For Isoenzymes

April 15, 1983

In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism

February 27, 1981

ACS Did Not Sign Bumpers Letter

May 1, 1992

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003